{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T06:07:04Z","timestamp":1759990024016},"reference-count":68,"publisher":"Microbiology Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,8,1]]},"abstract":"<jats:p>In 2000, a multi-valent pneumococcal conjugate vaccine, known as Prevnar, was licensed for use in infants and young children in the USA. The subsequent introduction of the vaccine into the childhood immunization schedule in that country led to a significant decrease in pneumococcal disease. The vaccine is effective against invasive and non-invasive pneumococcal infection, can be used in young children as well as adults and, like all conjugate vaccines, provides long-lasting immunity. Moreover, it reduces the incidence of antibiotic resistance because a number of resistant serotypes are targeted by the vaccine. Prevnar, also known as Prevenar, has since been licensed in numerous countries, including the UK. On 8 February 2006, the Departments of Health in England, Scotland and Wales announced the inclusion of Prevenar in the childhood immunization schedule. This announcement has important implications for pneumococcal infection, disease surveillance and immunization policy in the UK.<\/jats:p>","DOI":"10.1099\/jmm.0.46579-0","type":"journal-article","created":{"date-parts":[[2006,7,18]],"date-time":"2006-07-18T23:08:08Z","timestamp":1153264088000},"page":"975-980","source":"Crossref","is-referenced-by-count":16,"title":["Control of pneumococcal disease in the United Kingdom \u2013 the start of a new era"],"prefix":"10.1099","volume":"55","author":[{"given":"Stuart C.","family":"Clarke","sequence":"first","affiliation":[{"name":"Hampshire and Isle of Wight Health Protection Unit, Oakley Road and Molecular Microbiology Group, Division of Infection Inflammation and Repair, University of Southampton Medical School, Southampton, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"345","reference":[{"key":"R1","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1086\/313977","article-title":"& 11 other authors","volume":"31","author":"Ament","year":"2000","journal-title":"Clin Infect Dis"},{"key":"R2","article-title":"Study Evaluating Pneumococcal Vaccine in Healthy Infants","year":"2006"},{"key":"R3","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1128\/CMR.16.2.308-318.2003","article-title":"Pneumococcal vaccination and revaccination of older adults","volume":"16","author":"Artz","year":"2003","journal-title":"Clin Microbiol Rev"},{"key":"R4","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1128\/JCM.44.3.999-1017.2006","article-title":"& 9 other authors","volume":"44","author":"Beall","year":"2006","journal-title":"J Clin Microbiol"},{"key":"R5","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/00006454-200112000-00002","article-title":"Postlicensure evaluation of the effectiveness of seven valent pneumococcal conjugate vaccine","volume":"20","author":"Black","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"R6","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1097\/00006454-200209000-00005","article-title":"& 8 other authors","volume":"21","author":"Black","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"R7","article-title":"Streptorix \u2013 Going Beyond Prevnar","author":"Breuer","year":"2005"},{"key":"R8","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1542\/peds.2004-0778","article-title":"Effect of pneumococcal vaccination on quality of life in children with recurrent acute otitis media: a randomized, controlled trial","volume":"115","author":"Brouwer","year":"2005","journal-title":"Pediatrics"},{"key":"R9","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1086\/338460","article-title":"& 8 other authors","volume":"34","author":"Byington","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1086\/430604","article-title":"& 9 other authors","volume":"41","author":"Byington","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R11","first-page":"1","article-title":"Centers for Disease Control and Prevention","volume":"49","year":"2000","journal-title":"Morb Mortal Wkly Rep"},{"key":"R12","first-page":"893","article-title":"Centers for Disease Control and Prevention","volume":"54","year":"2005","journal-title":"Morb Mortal Wkly Rep"},{"key":"R13","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1128\/JCM.41.1.512-513.2003","article-title":"Meningitis due to mixed infection with penicillin-resistant and penicillin-susceptible strains of Streptococcus pneumoniae","volume":"41","author":"Chaves","year":"2003","journal-title":"J Clin Microbiol"},{"key":"R14","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1099\/jmm.0.45737-0","article-title":"Erythromycin resistance in invasive serotype 14 pneumococci is highly related to clonal type","volume":"53","author":"Clarke","year":"2004a","journal-title":"J Med Microbiol"},{"key":"R15","doi-asserted-by":"crossref","first-page":"4449","DOI":"10.1128\/JCM.42.10.4449-4452.2004","article-title":"Serotypes and sequence types of pneumococci causing invasive disease in Scotland prior to the introduction of pneumococcal conjugate polysaccharide vaccines","volume":"42","author":"Clarke","year":"2004b","journal-title":"J Clin Microbiol"},{"key":"R16","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1080\/09674845.2005.11732684","article-title":"Erythromycin resistance among invasive pneumococci in Scotland, 1994\u20132003","volume":"62","author":"Clarke","year":"2005","journal-title":"Br J Biomed Sci"},{"key":"R17","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1128\/JCM.44.4.1224-1228.2006","article-title":"Potential impact of conjugate vaccine on the incidence of invasive pneumococcal disease among children in Scotland","volume":"44","author":"Clarke","year":"2006a","journal-title":"J Clin Microbiol"},{"key":"R18","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1099\/jmm.0.46550-0","article-title":"Pneumococci causing invasive disease in children prior to the introduction of pneumococcal conjugate vaccine in Scotland","volume":"55","author":"Clarke","year":"2006b","journal-title":"J Med Microbiol"},{"key":"R19","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1089\/mdr.1998.4.51","article-title":"Serotype 19A variants of the Spanish serotype 23F multiresistant clone of Streptococcus pneumoniae","volume":"4","author":"Coffey","year":"1998","journal-title":"Microb Drug Resist"},{"key":"R20","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1099\/13500872-145-8-2023","article-title":"Serotype 14 variants of the Spanish penicillin-resistant serotype 9V clone of Streptococcus pneumoniae arose by large recombinational replacements of the cpsA\u2013pbp1a region","volume":"145","author":"Coffey","year":"1999","journal-title":"Microbiology"},{"key":"R21","article-title":"Clonality of serotypes of amoxicillin resistant isolates of Streptococcus pneumoniae from 1997 to 2003 in Cleveland","author":"Cordeiro","year":"2005","journal-title":"In Abstracts of the 105th General Meeting of the American Society for Microbiology 2005 , abstract C-121"},{"key":"R22","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1086\/499248","article-title":"Capsular type and the pneumococcal human host-parasite relationship","volume":"42","author":"Crook","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R23","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000422","article-title":"Vaccines for preventing pneumococcal infection in adults","author":"Dear","year":"2003"},{"key":"R24","doi-asserted-by":"crossref","first-page":"719","DOI":"10.2165\/00019053-200422110-00003","article-title":"Economic aspects of pneumococcal pneumonia: a review of the literature","volume":"22","author":"De Graeve","year":"2004","journal-title":"Pharmacoeconomics"},{"key":"R25","volume-title":"Extending meningitis C vaccine to 20\u201324\u2005year olds; pneumococcal vaccine for at-risk 2\u2005year olds , PL\/CMO\/2002\/1","year":"2002"},{"key":"R26","volume-title":"Adult immunisation update. Introduction of a pneumococcal immunisation programme for those aged 80\u2005years and over , PL\/CMO\/2003\/6","year":"2003"},{"key":"R27","volume-title":"The pneumococcal immunisation programme for older people and risk groups , PL\/CMO\/2005\/1","year":"2005"},{"key":"R28","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1469-0691.1999.tb00430.x","article-title":"Role of nasopharyngeal bacterial flora in the evaluation of recurrent middle ear infections in children","volume":"5","author":"Dhooge","year":"1999","journal-title":"Clin Microbiol Infect"},{"key":"R29","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM200102083440602","article-title":"& 9 other authors","volume":"344","author":"Eskola","year":"2001","journal-title":"N Engl J Med"},{"key":"R30","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/00006454-200301000-00006","article-title":"Impact of the pneumococcal conjugate vaccine on otitis media","volume":"22","author":"Fireman","year":"2003","journal-title":"Pediatr Infect Dis J"},{"issue":"issue 21","key":"R31","article-title":"Invasive pneumococcal infection England and Wales 1999","volume":"11","author":"George","year":"2001","journal-title":"CDR Weekly"},{"key":"R32","first-page":"R159","article-title":"Serogroups\/types and antibiotic resistance of referred isolates of Streptococcus pneumoniae : 1993 to 1995","volume":"7","author":"George","year":"1997","journal-title":"Commun Dis Rep CDR Rev"},{"key":"R33","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1128\/JCM.41.9.4194-4216.2003","article-title":"& 8 other authors","volume":"41","author":"Gertz","year":"2003","journal-title":"J Clin Microbiol"},{"key":"R34","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/S0140-6736(00)04222-7","article-title":"Geographical differences in invasive pneumococcal disease rates and serotype frequency in young children","volume":"357","author":"Hausdorff","year":"2001","journal-title":"Lancet"},{"key":"R35","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1136\/adc.86.6.396","article-title":"The UK Hib vaccine experience","volume":"86","author":"Heath","year":"2002","journal-title":"Arch Dis Child"},{"key":"R36","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1128\/JCM.33.10.2759-2762.1995","article-title":"Six newly recognized types of Streptococcus pneumoniae","volume":"33","author":"Henrichsen","year":"1995","journal-title":"J Clin Microbiol"},{"key":"R37","doi-asserted-by":"crossref","first-page":"5681","DOI":"10.1128\/JCM.42.12.5681-5688.2004","article-title":"Genetic analysis of diverse disease-causing pneumococci indicates high levels of diversity within serotypes and capsule switching","volume":"42","author":"Jefferies","year":"2004","journal-title":"J Clin Microbiol"},{"key":"R38","year":"2004"},{"key":"R39","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1017\/S0950268800004787","article-title":"Serotypes\/groups distribution and antimicrobial resistance of invasive pneumococcal isolates: implications for vaccine strategies","volume":"125","author":"Kyaw","year":"2000","journal-title":"Epidemiol Infect"},{"key":"R40","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1017\/S0950268801006586","article-title":"Incidence of invasive pneumococcal disease in Scotland, 1988-99","volume":"128","author":"Kyaw","year":"2002","journal-title":"Epidemiol Infect"},{"key":"R41","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1086\/379016","article-title":"Invasive pneumococcal disease in Scotland, 1999-2001: use of record linkage to explore associations between patients and disease in relation to future vaccination policy","volume":"37","author":"Kyaw","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R42","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1086\/431521","article-title":"The influence of chronic illnesses on the incidence of invasive pneumococcal disease in adults","volume":"192","author":"Kyaw","year":"2005","journal-title":"J Infect Dis"},{"key":"R43","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/00008480-200102000-00013","article-title":"Pneumococcal conjugate vaccine","volume":"13","author":"Ledwith","year":"2001","journal-title":"Curr Opin Pediatr"},{"key":"R44","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1001\/jama.294.16.2043","article-title":"& 10 other authors","volume":"294","author":"Lexau","year":"2005","journal-title":"JAMA (J Am Med Assoc)"},{"key":"R45","doi-asserted-by":"crossref","DOI":"10.1001\/jama.283.11.1460","article-title":"Projected cost-effectiveness of pneumococcal conjugate vaccination of healthy infants and young children","volume":"283","author":"Lieu","year":"2000","journal-title":"JAMA (J Am Med Assoc)"},{"key":"R46","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1086\/430608","article-title":"Capsules, clones, and curious events: pneumococcus under fire from polysaccharide conjugate vaccine","volume":"41","author":"Long","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R47","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/S0140-6736(02)08679-8","article-title":"Carriage of serogroup C meningococci 1\u2005year after meningococcal C conjugate polysaccharide vaccination","volume":"359","author":"Maiden","year":"2002","journal-title":"Lancet"},{"key":"R48","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/01.inf.0000055063.40314.da","article-title":"& 8 other authors","volume":"22","author":"Marchisio","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"R49","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1001\/jama.287.23.3096","article-title":"Trends in antimicrobial prescribing rates for children and adolescents","volume":"287","author":"McCaig","year":"2002","journal-title":"JAMA (J Am Med Assoc)"},{"key":"R50","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s10096-005-1313-y","article-title":"Clonal analysis of invasive pneumococcal isolates in Scotland and coverage of serotypes by the licensed conjugate polysaccharide pneumococcal vaccine: possible implications for UK vaccine policy","volume":"24","author":"McChlery","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R51","doi-asserted-by":"crossref","first-page":"969","DOI":"10.3201\/eid1106.050119","article-title":"Erythromycin-nonsusceptible Streptococcus pneumoniae in children, 1999-2001","volume":"11","author":"McEllistrem","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"R52","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1586\/14760584.3.4.433","article-title":"Cost-effectiveness studies of pneumococcal conjugate vaccines","volume":"3","author":"McIntosh","year":"2004","journal-title":"Expert Rev Vaccines"},{"key":"R53","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1128\/JCM.41.1.386-392.2003","article-title":"Stability of serotypes during nasopharyngeal carriage of Streptococcus pneumoniae","volume":"41","author":"Meats","year":"2003","journal-title":"J Clin Microbiol"},{"key":"R54","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1016\/j.vaccine.2004.05.003","article-title":"Cost-effectiveness analysis of pneumococcal conjugate vaccination in England and Wales","volume":"22","author":"Melegaro","year":"2004a","journal-title":"Vaccine"},{"key":"R55","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1023\/B:EJEP.0000024701.94769.98","article-title":"The 23-valent pneumococcal polysaccharide vaccine. Part I. Efficacy of PPV in the elderly: a comparison of meta-analyses","volume":"19","author":"Melegaro","year":"2004b","journal-title":"Eur J Epidemiol"},{"key":"R56","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1651-2227.2000.tb00776.x","article-title":"Epidemiology of invasive and other pneumococcal disease in children in England and Wales 1996-1998","volume":"89","author":"Miller","year":"2000","journal-title":"Acta Paediatr Suppl"},{"key":"R57","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1086\/514242","article-title":"Capsular transformation of a multidrug-resistant Streptococcus pneumoniae in vivo","volume":"177","author":"Nesin","year":"1998","journal-title":"J Infect Dis"},{"key":"R58","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/S0264-410X(02)00807-1","article-title":"The potential indirect effect of conjugate pneumococcal vaccines","volume":"21","author":"O'Brien","year":"2003","journal-title":"Vaccine"},{"key":"R59","doi-asserted-by":"crossref","first-page":"5440","DOI":"10.1128\/JCM.43.11.5440-5444.2005","article-title":"Clonal association between Streptococcus pneumoniae serotype 23A, circulating within the United States, and an internationally dispersed clone of serotype 23F","volume":"43","author":"Pai","year":"2005","journal-title":"J Clin Microbiol"},{"key":"R60","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1586\/14760584.1.1.65","article-title":"Pneumococcal conjugate vaccine: economic issues of the introduction of a new childhood vaccine","volume":"1","author":"Ray","year":"2002","journal-title":"Expert Rev Vaccines"},{"key":"R61","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1086\/317924","article-title":"& 8 other authors","volume":"183","author":"Sleeman","year":"2001","journal-title":"J Infect Dis"},{"key":"R62","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/S0140-6736(00)02779-3","article-title":"Prevention of pneumococcal disease by vaccination: does serotype replacement matter?","volume":"356","author":"Spratt","year":"2000","journal-title":"Lancet"},{"key":"R63","doi-asserted-by":"crossref","first-page":"5783","DOI":"10.1128\/JCM.41.12.5783-5786.2003","article-title":"First report of capsule replacement among electrophoretic type 37 Neisseria meningitidis strains in Italy","volume":"41","author":"Stefanelli","year":"2003","journal-title":"J Clin Microbiol"},{"key":"R64","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0140-6736(05)71043-6","article-title":"& 8 other authors","volume":"365","author":"Stephens","year":"2005","journal-title":"Lancet"},{"key":"R65","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1073\/pnas.94.1.271","article-title":"Capsule switching of Neisseria meningitidis","volume":"94","author":"Swartley","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R66","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1086\/322048","article-title":"Nasopharyngeal carriage of Streptococcus pneumoniae in Finnish children younger than 2\u2005years old","volume":"184","author":"Syrjanen","year":"2001","journal-title":"J Infect Dis"},{"key":"R67","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":"& 10 other authors","volume":"348","author":"Whitney","year":"2003","journal-title":"N Engl J Med"},{"key":"R68","doi-asserted-by":"crossref","first-page":"3843","DOI":"10.1016\/j.vaccine.2005.01.158","article-title":"If pneumonia is the \u201cold man's friend\u201d, should it be prevented by vaccination? An ethical analysis","volume":"23","author":"Zimmerman","year":"2005","journal-title":"Vaccine"}],"container-title":["Journal of Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.microbiologyresearch.org\/content\/journal\/jmm\/10.1099\/jmm.0.46579-0?crawler=true","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T03:38:03Z","timestamp":1600832283000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.microbiologyresearch.org\/content\/journal\/jmm\/10.1099\/jmm.0.46579-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8,1]]},"references-count":68,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2006,8,1]]}},"URL":"https:\/\/doi.org\/10.1099\/jmm.0.46579-0","relation":{},"ISSN":["0022-2615","1473-5644"],"issn-type":[{"value":"0022-2615","type":"print"},{"value":"1473-5644","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,8,1]]}}}